Grifols Shares Outstanding 2012-2018 | GRFS

Grifols shares outstanding history from 2012 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Grifols shares outstanding for the quarter ending September 30, 2018 were 0.000B, a 100% decline year-over-year.
  • Grifols 2018 shares outstanding were 0.686B, a 0.23% increase from 2017.
  • Grifols 2017 shares outstanding were 0.684B, a 0.15% increase from 2016.
  • Grifols 2016 shares outstanding were 0.683B, a 0.35% decline from 2015.
Grifols Annual Shares Outstanding
(Millions of Shares)
2018 686
2017 684
2016 683
2015 686
2014 687
2013 684
2012 685
2011 556
Grifols Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 0
Q2 2018 675
Q2 2017 685
Q1 2017 670
Q4 2016 683
Q3 2016 675
Q2 2016 696
Q1 2016 696
Q4 2015 0
Q3 2015 683
Q2 2015 682
Q1 2015 676
Q4 2014 691
Q3 2014 692
Q2 2014 692
Q1 2014 691
Q4 2013 714
Q3 2013 674
Q2 2013 673
Q1 2013 663
Q4 2012 791
Q3 2012 670
Q2 2012 693
Q1 2012 675
Q4 2011 912
Q3 2011 572
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.208B $5.299B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $46.810B 31.14
Takeda Pharmaceutical (TAK) Japan $33.231B 12.30
Ionis Pharmaceuticals (IONS) United States $11.005B 34.13
Neurocrine Biosciences (NBIX) United States $7.703B 498.88
Jazz Pharmaceuticals (JAZZ) Ireland $7.671B 10.98
Sage Therapeutics (SAGE) United States $7.388B 0.00
Tilray (TLRY) United States $6.730B 0.00
Catalent (CTLT) United States $6.200B 25.96
Nektar Therapeutics (NKTR) United States $6.081B 9.70
United Therapeutics (UTHR) United States $5.196B 8.84
FibroGen (FGEN) United States $4.764B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.283B 22.76
Taro Pharmaceutical Industries (TARO) Israel $4.238B 13.64
Zogenix (ZGNX) United States $2.224B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.215B 0.00
Portola Pharmaceuticals (PTLA) United States $2.208B 0.00
PTC Therapeutics (PTCT) United States $2.149B 0.00
Aerie Pharmaceuticals (AERI) United States $2.140B 0.00
USANA Health Sciences (USNA) United States $2.129B 17.87
Ironwood Pharmaceuticals (IRWD) United States $2.072B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.994B 24.83
Endo (ENDP) Ireland $1.928B 2.97
Heron Therapeutics (HRTX) United States $1.908B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.779B 0.00
Xencor (XNCR) United States $1.712B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.625B 140.79
Corcept Therapeutics (CORT) United States $1.412B 20.52
Theravance Biopharma (TBPH) Cayman Islands $1.338B 0.00
TherapeuticsMD (TXMD) United States $1.334B 0.00
Esperion Therapeutics (ESPR) United States $1.302B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.158B 0.00
Tricida (TCDA) United States $1.091B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.895B 0.00
Radius Health (RDUS) United States $0.860B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.612B 0.00
Odonate Therapeutics (ODT) United States $0.611B 0.00
Collegium Pharmaceutical (COLL) United States $0.587B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.573B 0.00
Forty Seven (FTSV) United States $0.559B 0.00
ChemoCentryx (CCXI) United States $0.545B 0.00
GlycoMimetics (GLYC) United States $0.541B 0.00
Dermira (DERM) United States $0.531B 0.00
ArQule (ARQL) United States $0.521B 0.00
Siga Technologies (SIGA) United States $0.490B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.486B 28.64
Akebia Therapeutics (AKBA) United States $0.466B 0.00
KalVista Pharmaceuticals (KALV) United States $0.454B 0.00
Flexion Therapeutics (FLXN) United States $0.453B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.442B 0.00
Translate Bio (TBIO) United States $0.434B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.430B 0.00
TCR2 THERAPTCS (TCRR) United States $0.419B 0.00
Concert Pharmaceuticals (CNCE) United States $0.395B 0.00
ImmunoGen (IMGN) United States $0.387B 0.00
Aptorum Group (APM) China $0.378B 0.00
OptiNose (OPTN) United States $0.376B 0.00
Minerva Neurosciences (NERV) United States $0.329B 0.00
Karyopharm Therapeutics (KPTI) United States $0.323B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.316B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.316B 0.00
CASI Pharmaceuticals (CASI) United States $0.314B 0.00
Lannett Co Inc (LCI) United States $0.310B 2.88
HARPOON THERAPT (HARP) United States $0.299B 0.00
Mast Therapeutics (SVRA) United States $0.292B 0.00
Majesco Entertainment (PTE) United States $0.283B 0.00
Immune Design (IMDZ) United States $0.282B 0.00
Aclaris Therapeutics (ACRS) United States $0.278B 0.00
Xeris Pharmaceuticals (XERS) United States $0.277B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.274B 10.14
MARKER THERAPEUTICS, INC (MRKR) United States $0.257B 0.00
Calithera Biosciences (CALA) United States $0.256B 0.00
Dova Pharmaceuticals (DOVA) United States $0.253B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.250B 0.00
Affimed (AFMD) Germany $0.245B 0.00
Tyme Technologies (TYME) United States $0.242B 0.00
ElectroCore (ECOR) United States $0.235B 0.00
Opexa Therapeutics (ACER) United States $0.235B 0.00
Galectin Therapeutics (GALT) United States $0.230B 0.00
Jounce Therapeutics (JNCE) United States $0.218B 0.00
Aldeyra Therapeutics (ALDX) United States $0.217B 0.00
MEI Pharma (MEIP) United States $0.214B 0.00
IMV INC (IMV) Canada $0.208B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.206B 0.00
Ardelyx (ARDX) United States $0.205B 0.00
Recro Pharma (REPH) United States $0.198B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.197B 0.00
Molecular Templates (MTEM) United States $0.195B 0.00
Nature's Sunshine Products (NATR) United States $0.194B 201.80
Aratana Therapeutics (PETX) United States $0.187B 0.00
Redhill Biopharma (RDHL) Israel $0.186B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.185B 0.00
Rafael Holdings (RFL) United States $0.182B 0.00
Ocular Therapeutix (OCUL) United States $0.174B 0.00
Aquestive Therapeutics (AQST) United States $0.172B 0.00
Neon Therapeutics (NTGN) United States $0.165B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.158B 0.00
China SXT Pharmaceuticals (SXTC) China $0.157B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.156B 0.00
AgeX Therapeutics (AGE) United States $0.150B 0.00
Cardiome Pharma (CORV) Canada $0.144B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.144B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.139B 0.00
MediWound (MDWD) Israel $0.138B 0.00
ProNAi Therapeutics (SRRA) Canada $0.138B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.124B 0.00
DURECT (DRRX) United States $0.122B 0.00
Champions Oncology (CSBR) United States $0.122B 0.00
Zafgen (ZFGN) United States $0.114B 0.00
Adherex Technologies (FENC) United States $0.113B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.113B 0.00
Infinity Pharmaceuticals (INFI) United States $0.102B 0.00
Nivalis Therapeutics (ALPN) United States $0.100B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.092B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.092B 0.00
India Globalization Capital (IGC) United States $0.089B 0.00
Otonomy (OTIC) United States $0.089B 0.00
Natural Alternatives (NAII) United States $0.085B 8.34
Genocea Biosciences (GNCA) United States $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.081B 0.00
SCYNEXIS (SCYX) United States $0.081B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.079B 0.00
Iterum Therapeutics (ITRM) Ireland $0.078B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.073B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.072B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.069B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.063B 0.00
Avenue Therapeutics (ATXI) United States $0.062B 0.00
CTI BioPharma (CTIC) United States $0.059B 0.00
Melinta Therapeutics (MLNT) United States $0.057B 0.00
Forward Pharma (FWP) Denmark $0.057B 0.00
Capnia (SLNO) United States $0.055B 0.00
KemPharm (KMPH) United States $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00
Lipocine (LPCN) United States $0.051B 0.00
BioLineRx (BLRX) Israel $0.047B 0.00
Mannatechorporated (MTEX) United States $0.043B 0.00
ProPhase Labs (PRPH) United States $0.039B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.037B 0.00
Achaogen (AKAO) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.033B 0.00
NOVAN INC (NOVN) United States $0.030B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
ContraFect (CFRX) United States $0.030B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.027B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
PharmAthene (ALT) United States $0.026B 0.00
IsoRay (ISR) United States $0.025B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Onconova Therapeutics (ONTX) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Can-Fite Biopharma (CANF) Israel $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.023B 0.00
Pain Therapeutics (PTIE) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.022B 0.00
Achieve Life Sciences (ACHV) United States $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
Xenetic Biosciences (XBIO) United States $0.020B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.020B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Shineco (TYHT) China $0.015B 2.54
Auris Medical Holding AG (EARS) Switzerland $0.014B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
VAXART, INC (VXRT) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.006B 0.00
Intellipharmaceutics (IPCI) Canada $0.005B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00